Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery

Author

Kim, Uoo

Source

Case Reports in Anesthesiology

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-12-24

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Medicine

Abstract EN

Anesthetic management for patients with certain neuromuscular disorders may be challenging due to contraindications to triggering agents secondary to increased susceptibility for malignant hyperthermia (MH).

Inclusion body myositis (IBM) is an inflammatory muscle disease that causes concern for the anesthesiologist due to potential respiratory muscle weakness and hyperkalemia with succinylcholine.

Elevated serum creatinine kinase levels found in IBM also raise the possibility of increased susceptibility to MH.

This case report describes a successful anesthetic course with special considerations in a patient with IBM undergoing general anesthesia for coronary artery bypass grafting (CABG) under cardiopulmonary bypass (CPB) using total intravenous anesthesia (TIVA).

American Psychological Association (APA)

Kim, Uoo. 2020. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1145955

Modern Language Association (MLA)

Kim, Uoo. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1145955

American Medical Association (AMA)

Kim, Uoo. Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery. Case Reports in Anesthesiology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1145955

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1145955